Form 483

Alphapharm Pty Ltd Form 483, 2024-06-28

FDA issued a Form 483 to Alphapharm Pty Ltd on 2024-06-28 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Alphapharm Pty Ltd · Carole Park, Australia · Issued June 28, 2024

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 Jun 2024
21 CFR 211.100(b)

Procedure Deviations Recorded and Justified

Cited by Anastasia M Shields

28 Jun 2024
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Anastasia M Shields

Inspected site

APAlphapharm Pty LtdCarole Park, Australia

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 2 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere